Pegasus Companies Inc
OTC:PEGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pegasus Companies Inc
OTC:PEGX
|
US |
|
Van de Velde NV
F:VO4
|
BE |
|
O
|
Opus Global Nyrt
F:1VY
|
HU |
|
A
|
An Phat Bioplastics JSC
VN:AAA
|
VN |
|
M
|
MegaPro Biomedical Co Ltd
TPEX:6827
|
TW |
|
S
|
Sen X PCL
SET:SENX
|
TH |
|
E
|
EMCORE Corp
F:ER2N
|
US |
|
Sabre Gold Mines Corp
TSX:SGLD
|
CA |
|
S
|
Skinwallet SA
WSE:SWT
|
PL |
|
KS Terminals Inc
TWSE:3003
|
TW |
|
Electrovaya Inc
F:4EV0
|
CA |
|
Afentra PLC
F:TB8A
|
UK |
|
Percheron Therapeutics Ltd
ASX:PER
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PEGX's stock price target?
Not Available
PEGX does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Pegasus Companies Inc?
Projected CAGR
365%
Over the last 12 years, the compound annual growth rate for Revenue has been -20%. The projected CAGR for the next 4 years is 365%.